In this context, it has been shown that the activation of the proinflammatory NF-kB pathway has a tumor prosurvival effect, giving chemotherapy resistance to cancer cells in an Akt-independent pathway, but involving the epidermal growth factor (EGF) activating signaling [89]. Here, EGF is linked to cancer.